Fatigue in the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 3
Monitoring fatigue effectively evaluates a patient's overall quality of life and disease progression, making it a key indicator. Future treatments can target specific brain regions, with their effectiveness being evaluated through FS-14 assessments of fatigue changes.
Authors
- Meng-Cheng Li
- Wan-jin CHEN
- Wei Lin (ORCID: https://orcid.org/0000-0002-0832-7548)
- Lan Xiao (ORCID: https://orcid.org/0000-0002-5227-9352)
- Z Z Chen
- Min‐Ting Lin
- Ning Wang (ORCID: https://orcid.org/0000-0003-3542-0948)
- Ying Fu (ORCID: https://orcid.org/0000-0002-1590-3945)
- Liangliang Qiu (ORCID: https://orcid.org/0000-0002-1983-3331)
- Zhixian Ye (ORCID: https://orcid.org/0000-0003-3686-046X)
- Yuanyuan Zhang (ORCID: https://orcid.org/0000-0002-3662-4398)
- Chun Li (ORCID: https://orcid.org/0000-0001-8643-9679)
- Z M Zhu
- Shi-Rui Gan
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/ene.70093
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China